GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
78 hedge funds and large institutions have $571M invested in GenMark Diagnostics, Inc in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 13 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
52% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 21
40% more capital invested
Capital invested by funds: $407M → $571M (+$164M)
3.35% more ownership
Funds ownership: 97.75% → 101.1% (+3.4%)
0% more funds holding
Funds holding: 78 → 78 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
+$22.1M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$4.44M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$848K |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$798K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$678K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$4.28M |
| 2 |
JP Morgan Chase
New York
|
-$3.58M |
| 3 |
Millennium Management
New York
|
-$2.54M |
| 4 |
VAM
Visium Asset Management
New York
|
-$1.87M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.76M |
GNMK Hedge Fund Activity: Q2 2014 in Review
78 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2014, worth a combined $571M — up 40% from $407M a quarter earlier.
Fund positioning in GNMK was balanced in Q2 2014: 13 funds opened new positions, 13 closed out, 32 added to existing stakes and 21 trimmed.
The largest buyer was Parnassus Investments, opening a new position worth an estimated $22.1M. The largest seller was Jennison Associates, cutting an estimated $4.28M.
- 78 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $571M of GenMark Diagnostics, Inc stock for Q2 2014, up 40% quarter-over-quarter.
- 13 funds opened new GenMark Diagnostics, Inc positions in Q2 2014 and 13 closed out, a net change of 0 holders.
- The largest GenMark Diagnostics, Inc buyer in Q2 2014 was Parnassus Investments, an estimated $22.1M added.
- The largest GenMark Diagnostics, Inc seller in Q2 2014 was Jennison Associates, an estimated $4.28M sold.
Based on aggregated 13F filings for Q2 2014.